These are a type of medicine called GLP-1 agonists, and they can be very helpful as an extra tool in weight loss
Works well and was shipped quickly
Why real-world tirzepatide results sometimes fall short Post-marketing data and patient surveys suggest that average real-world weight loss with tirzepatide is approximately 15-18% at one year, somewhat below the 20.9% seen in SURMOUNT-1 at 72 weeks
Many find that eating smaller meals more frequently prevents the heavy, slow-digesting feeling that triggers reflux
If you experience heavy periods whilst taking Ozempic, it is essential to consult your GP to exclude other important causes and determine appropriate management
To view a copy of this licence, visit About this article Cite this article Yin, M., Palsson-McDermott, E.M., Henry, .C